Home›Search›NeuroMolecular Medicine

NeuroMolecular Medicine

Springer · United States · Est. 1986

ISSN1535-1084eISSN1559-1174

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.979

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.843

Total Worksi

1,112

Total Citationsi

43,964

2yr Mean Citednessi

2.93

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

NeuroMolecular Medicine focuses on publishing research about the genetic, molecular, and biochemical basis of various neurological disorders. Encompasses basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death. Coverage ranges from genetic analyses of human populations to animal and cell culture models of neurological disorders. Committed to publishing studies that provide mechanistic insights and relevance to disease models. High author satisfaction with 100% of surveyed authors indicating they would likely publish in the journal again.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1986

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications1,112

Publisher OrgSpringer Science+Business Media

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Springer

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1535-1084 / 1559-1174

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2.3k

2019

1.5k

2020

2021

590

2022

390

2023

287

2024

247

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Molecular MedicineQ2

NeurologyQ2

Cellular and Molecular NeuroscienceQ3

Subject Classification

Web of Science Categories

Neurosciences

Scopus Categories

Cellular and Molecular NeuroscienceNeurologyMolecular Medicine

Research Topics (OpenAlex)

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsMitochondrial Function and PathologyNeuroscience and Neuropharmacology ResearchParkinson's Disease Mechanisms and TreatmentsMicroRNA in disease regulationNerve injury and regenerationNeurogenesis and neuroplasticity mechanismsGenetic Neurodegenerative DiseasesGenetics and Neurodevelopmental Disorders

Frequently asked questions about NeuroMolecular Medicine

Is NeuroMolecular Medicine a predatory journal?

PubScope has no integrity flags on record for NeuroMolecular Medicine: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of NeuroMolecular Medicine?

NeuroMolecular Medicine is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.93.

Is NeuroMolecular Medicine indexed in Scopus and Web of Science?

NeuroMolecular Medicine is indexed in Web of Science, Scopus.